This trial will test whether a personalized treatment plan based on biomarkers can help reduce the risk of complications for people with coronary artery disease.
2 Primary · 5 Secondary · Reporting Duration: 5 years post intervention
Active Control
Experimental Treatment
450 Total Participants · 2 Treatment Groups
Primary Treatment: Medical/Behavioral therapy · No Placebo Group · N/A
Age 21 - 90 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: